nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP3A4—Everolimus—kidney cancer	0.0867	0.165	CbGbCtD
Nitric Oxide—CYP1A2—Pazopanib—kidney cancer	0.0587	0.112	CbGbCtD
Nitric Oxide—CYP3A4—Temsirolimus—kidney cancer	0.0586	0.112	CbGbCtD
Nitric Oxide—CYP2B6—Sorafenib—kidney cancer	0.0581	0.111	CbGbCtD
Nitric Oxide—CYP1A2—Erlotinib—kidney cancer	0.0419	0.0799	CbGbCtD
Nitric Oxide—CYP2B6—Doxorubicin—kidney cancer	0.0353	0.0673	CbGbCtD
Nitric Oxide—CYP1A2—Sorafenib—kidney cancer	0.0341	0.065	CbGbCtD
Nitric Oxide—CYP3A4—Pazopanib—kidney cancer	0.0308	0.0587	CbGbCtD
Nitric Oxide—CYP3A4—Erlotinib—kidney cancer	0.022	0.0419	CbGbCtD
Nitric Oxide—CYP3A4—Paclitaxel—kidney cancer	0.0201	0.0383	CbGbCtD
Nitric Oxide—CYP3A4—Sorafenib—kidney cancer	0.0179	0.0341	CbGbCtD
Nitric Oxide—CYP3A4—Vinblastine—kidney cancer	0.0176	0.0336	CbGbCtD
Nitric Oxide—CYP3A4—Vincristine—kidney cancer	0.0173	0.0331	CbGbCtD
Nitric Oxide—Pulmonary haemorrhage—Pazopanib—kidney cancer	0.0159	0.0645	CcSEcCtD
Nitric Oxide—CYP3A4—Sunitinib—kidney cancer	0.0145	0.0276	CbGbCtD
Nitric Oxide—Cerebral infarction—Pazopanib—kidney cancer	0.0111	0.0449	CcSEcCtD
Nitric Oxide—CYP3A4—Doxorubicin—kidney cancer	0.0108	0.0207	CbGbCtD
Nitric Oxide—Pulmonary haemorrhage—Sunitinib—kidney cancer	0.0105	0.0425	CcSEcCtD
Nitric Oxide—Haemorrhage intracranial—Temsirolimus—kidney cancer	0.00932	0.0379	CcSEcCtD
Nitric Oxide—Pulmonary haemorrhage—Vincristine—kidney cancer	0.00885	0.036	CcSEcCtD
Nitric Oxide—Atelectasis—Everolimus—kidney cancer	0.00873	0.0355	CcSEcCtD
Nitric Oxide—Cerebral infarction—Sunitinib—kidney cancer	0.00729	0.0296	CcSEcCtD
Nitric Oxide—Pneumothorax—Pazopanib—kidney cancer	0.00724	0.0294	CcSEcCtD
Nitric Oxide—CYP1A2—urine—kidney cancer	0.00643	0.0858	CbGeAlD
Nitric Oxide—Cerebral infarction—Vincristine—kidney cancer	0.00617	0.0251	CcSEcCtD
Nitric Oxide—Pneumothorax—Everolimus—kidney cancer	0.00572	0.0232	CcSEcCtD
Nitric Oxide—Pneumothorax—Sunitinib—kidney cancer	0.00478	0.0194	CcSEcCtD
Nitric Oxide—CYP3A4—urine—kidney cancer	0.00466	0.0621	CbGeAlD
Nitric Oxide—GUCY1A3—nephron tubule—kidney cancer	0.00439	0.0585	CbGeAlD
Nitric Oxide—GUCY1A3—renal system—kidney cancer	0.00399	0.0532	CbGeAlD
Nitric Oxide—GUCY1B3—renal system—kidney cancer	0.00396	0.0528	CbGeAlD
Nitric Oxide—Dry throat—Paclitaxel—kidney cancer	0.00389	0.0158	CcSEcCtD
Nitric Oxide—GUCY1A3—kidney—kidney cancer	0.00385	0.0514	CbGeAlD
Nitric Oxide—GUCY1B3—kidney—kidney cancer	0.00383	0.051	CbGeAlD
Nitric Oxide—GUCY1A3—cortex of kidney—kidney cancer	0.00375	0.0501	CbGeAlD
Nitric Oxide—GUCY1B3—cortex of kidney—kidney cancer	0.00373	0.0497	CbGeAlD
Nitric Oxide—ALDH2—nephron tubule—kidney cancer	0.0037	0.0493	CbGeAlD
Nitric Oxide—GUCY1A3—cardiac atrium—kidney cancer	0.00357	0.0476	CbGeAlD
Nitric Oxide—GUCY1B3—cardiac atrium—kidney cancer	0.00355	0.0473	CbGeAlD
Nitric Oxide—ALDH2—renal system—kidney cancer	0.00336	0.0448	CbGeAlD
Nitric Oxide—ALDH2—kidney—kidney cancer	0.00325	0.0433	CbGeAlD
Nitric Oxide—Chest discomfort—Everolimus—kidney cancer	0.00322	0.0131	CcSEcCtD
Nitric Oxide—Pneumothorax—Paclitaxel—kidney cancer	0.00321	0.013	CcSEcCtD
Nitric Oxide—ALDH2—cortex of kidney—kidney cancer	0.00316	0.0422	CbGeAlD
Nitric Oxide—ALDH2—gonad—kidney cancer	0.00301	0.0402	CbGeAlD
Nitric Oxide—ALDH2—cardiac atrium—kidney cancer	0.00301	0.0401	CbGeAlD
Nitric Oxide—Gastrointestinal haemorrhage—Temsirolimus—kidney cancer	0.00278	0.0113	CcSEcCtD
Nitric Oxide—Pneumothorax—Capecitabine—kidney cancer	0.00263	0.0107	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Pazopanib—kidney cancer	0.00262	0.0106	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Erlotinib—kidney cancer	0.00199	0.0081	CcSEcCtD
Nitric Oxide—Bradycardia—Pazopanib—kidney cancer	0.00184	0.00749	CcSEcCtD
Nitric Oxide—Haemoglobin—Pazopanib—kidney cancer	0.00182	0.00739	CcSEcCtD
Nitric Oxide—Haemorrhage—Pazopanib—kidney cancer	0.00181	0.00735	CcSEcCtD
Nitric Oxide—Chest discomfort—Paclitaxel—kidney cancer	0.0018	0.00733	CcSEcCtD
Nitric Oxide—Cardiac disorder—Temsirolimus—kidney cancer	0.00178	0.00724	CcSEcCtD
Nitric Oxide—Angiopathy—Temsirolimus—kidney cancer	0.00174	0.00708	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Temsirolimus—kidney cancer	0.00173	0.00704	CcSEcCtD
Nitric Oxide—Pneumothorax—Doxorubicin—kidney cancer	0.0017	0.0069	CcSEcCtD
Nitric Oxide—Cardiac disorder—Pazopanib—kidney cancer	0.00168	0.00683	CcSEcCtD
Nitric Oxide—CYP2B6—nephron tubule—kidney cancer	0.00166	0.0221	CbGeAlD
Nitric Oxide—Angiopathy—Pazopanib—kidney cancer	0.00164	0.00667	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Pazopanib—kidney cancer	0.00163	0.00663	CcSEcCtD
Nitric Oxide—CYP1A2—renal system—kidney cancer	0.00157	0.021	CbGeAlD
Nitric Oxide—CYP2B6—renal system—kidney cancer	0.00151	0.0201	CbGeAlD
Nitric Oxide—Chest discomfort—Capecitabine—kidney cancer	0.00148	0.00602	CcSEcCtD
Nitric Oxide—CYP2B6—kidney—kidney cancer	0.00146	0.0194	CbGeAlD
Nitric Oxide—Convulsion—Temsirolimus—kidney cancer	0.00145	0.00589	CcSEcCtD
Nitric Oxide—Haemoglobin—Vinblastine—kidney cancer	0.00144	0.00586	CcSEcCtD
Nitric Oxide—Haemoglobin—Everolimus—kidney cancer	0.00144	0.00584	CcSEcCtD
Nitric Oxide—Haemorrhage—Vinblastine—kidney cancer	0.00143	0.00583	CcSEcCtD
Nitric Oxide—Haemorrhage—Everolimus—kidney cancer	0.00143	0.00581	CcSEcCtD
Nitric Oxide—Chest pain—Temsirolimus—kidney cancer	0.00142	0.00579	CcSEcCtD
Nitric Oxide—Haemoglobin—Erlotinib—kidney cancer	0.00139	0.00563	CcSEcCtD
Nitric Oxide—Haemorrhage—Erlotinib—kidney cancer	0.00138	0.0056	CcSEcCtD
Nitric Oxide—CYP2B6—gonad—kidney cancer	0.00135	0.018	CbGeAlD
Nitric Oxide—Chest pain—Pazopanib—kidney cancer	0.00134	0.00545	CcSEcCtD
Nitric Oxide—Nervous system disorder—Temsirolimus—kidney cancer	0.00134	0.00544	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Temsirolimus—kidney cancer	0.00134	0.00543	CcSEcCtD
Nitric Oxide—Cardiac disorder—Everolimus—kidney cancer	0.00133	0.00539	CcSEcCtD
Nitric Oxide—Angiopathy—Everolimus—kidney cancer	0.0013	0.00527	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Everolimus—kidney cancer	0.00129	0.00523	CcSEcCtD
Nitric Oxide—Shock—Pazopanib—kidney cancer	0.00126	0.00514	CcSEcCtD
Nitric Oxide—Nervous system disorder—Pazopanib—kidney cancer	0.00126	0.00512	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Pazopanib—kidney cancer	0.00126	0.00512	CcSEcCtD
Nitric Oxide—Haemoglobin—Sorafenib—kidney cancer	0.00125	0.00507	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Erlotinib—kidney cancer	0.00124	0.00505	CcSEcCtD
Nitric Oxide—Haemorrhage—Sorafenib—kidney cancer	0.00124	0.00504	CcSEcCtD
Nitric Oxide—Dyspnoea—Temsirolimus—kidney cancer	0.00122	0.00494	CcSEcCtD
Nitric Oxide—Bradycardia—Sunitinib—kidney cancer	0.00121	0.00494	CcSEcCtD
Nitric Oxide—Haemoglobin—Sunitinib—kidney cancer	0.0012	0.00487	CcSEcCtD
Nitric Oxide—Haemorrhage—Sunitinib—kidney cancer	0.00119	0.00485	CcSEcCtD
Nitric Oxide—Cardiac disorder—Sorafenib—kidney cancer	0.00115	0.00468	CcSEcCtD
Nitric Oxide—Dyspnoea—Pazopanib—kidney cancer	0.00115	0.00466	CcSEcCtD
Nitric Oxide—CYP3A4—renal system—kidney cancer	0.00114	0.0152	CbGeAlD
Nitric Oxide—Angiopathy—Sorafenib—kidney cancer	0.00113	0.00457	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Sorafenib—kidney cancer	0.00112	0.00454	CcSEcCtD
Nitric Oxide—Cardiac disorder—Sunitinib—kidney cancer	0.00111	0.0045	CcSEcCtD
Nitric Oxide—CYP3A4—kidney—kidney cancer	0.0011	0.0147	CbGeAlD
Nitric Oxide—Angiopathy—Sunitinib—kidney cancer	0.00108	0.0044	CcSEcCtD
Nitric Oxide—Convulsion—Vinblastine—kidney cancer	0.00108	0.0044	CcSEcCtD
Nitric Oxide—Convulsion—Everolimus—kidney cancer	0.00108	0.00438	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Sunitinib—kidney cancer	0.00108	0.00437	CcSEcCtD
Nitric Oxide—Chest pain—Everolimus—kidney cancer	0.00106	0.0043	CcSEcCtD
Nitric Oxide—Chest pain—Erlotinib—kidney cancer	0.00102	0.00415	CcSEcCtD
Nitric Oxide—Shock—Everolimus—kidney cancer	0.000999	0.00406	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Vinblastine—kidney cancer	0.000998	0.00405	CcSEcCtD
Nitric Oxide—Nervous system disorder—Everolimus—kidney cancer	0.000995	0.00405	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Everolimus—kidney cancer	0.000994	0.00404	CcSEcCtD
Nitric Oxide—Shock—Erlotinib—kidney cancer	0.000963	0.00392	CcSEcCtD
Nitric Oxide—Haemoglobin—Gemcitabine—kidney cancer	0.000962	0.00391	CcSEcCtD
Nitric Oxide—Nervous system disorder—Erlotinib—kidney cancer	0.00096	0.0039	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Erlotinib—kidney cancer	0.000959	0.0039	CcSEcCtD
Nitric Oxide—Haemorrhage—Gemcitabine—kidney cancer	0.000957	0.00389	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000951	0.00387	CcSEcCtD
Nitric Oxide—Hypotension—Everolimus—kidney cancer	0.000948	0.00385	CcSEcCtD
Nitric Oxide—Cardiac disorder—Vincristine—kidney cancer	0.000937	0.00381	CcSEcCtD
Nitric Oxide—Angiopathy—Vincristine—kidney cancer	0.000916	0.00372	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Vincristine—kidney cancer	0.00091	0.0037	CcSEcCtD
Nitric Oxide—Dyspnoea—Everolimus—kidney cancer	0.000905	0.00368	CcSEcCtD
Nitric Oxide—Dizziness—Temsirolimus—kidney cancer	0.000902	0.00367	CcSEcCtD
Nitric Oxide—Convulsion—Sunitinib—kidney cancer	0.0009	0.00366	CcSEcCtD
Nitric Oxide—Cardiac disorder—Gemcitabine—kidney cancer	0.000889	0.00361	CcSEcCtD
Nitric Oxide—Chest pain—Sunitinib—kidney cancer	0.000884	0.00359	CcSEcCtD
Nitric Oxide—Dyspnoea—Erlotinib—kidney cancer	0.000873	0.00355	CcSEcCtD
Nitric Oxide—Angiopathy—Gemcitabine—kidney cancer	0.000869	0.00353	CcSEcCtD
Nitric Oxide—Shock—Sorafenib—kidney cancer	0.000867	0.00352	CcSEcCtD
Nitric Oxide—Nervous system disorder—Sorafenib—kidney cancer	0.000864	0.00351	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Gemcitabine—kidney cancer	0.000863	0.00351	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Sorafenib—kidney cancer	0.000863	0.00351	CcSEcCtD
Nitric Oxide—Headache—Temsirolimus—kidney cancer	0.000855	0.00347	CcSEcCtD
Nitric Oxide—Dizziness—Pazopanib—kidney cancer	0.00085	0.00346	CcSEcCtD
Nitric Oxide—Shock—Sunitinib—kidney cancer	0.000834	0.00339	CcSEcCtD
Nitric Oxide—Nervous system disorder—Sunitinib—kidney cancer	0.000831	0.00338	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Sunitinib—kidney cancer	0.00083	0.00337	CcSEcCtD
Nitric Oxide—Bradycardia—Paclitaxel—kidney cancer	0.000816	0.00332	CcSEcCtD
Nitric Oxide—Haemoglobin—Paclitaxel—kidney cancer	0.000806	0.00327	CcSEcCtD
Nitric Oxide—Headache—Pazopanib—kidney cancer	0.000805	0.00327	CcSEcCtD
Nitric Oxide—Haemorrhage—Paclitaxel—kidney cancer	0.000802	0.00326	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000786	0.00319	CcSEcCtD
Nitric Oxide—Dyspnoea—Sorafenib—kidney cancer	0.000785	0.00319	CcSEcCtD
Nitric Oxide—Convulsion—Vincristine—kidney cancer	0.000761	0.00309	CcSEcCtD
Nitric Oxide—Dyspnoea—Sunitinib—kidney cancer	0.000756	0.00307	CcSEcCtD
Nitric Oxide—Cardiac disorder—Paclitaxel—kidney cancer	0.000744	0.00302	CcSEcCtD
Nitric Oxide—Angiopathy—Paclitaxel—kidney cancer	0.000727	0.00296	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Paclitaxel—kidney cancer	0.000722	0.00294	CcSEcCtD
Nitric Oxide—Chest pain—Gemcitabine—kidney cancer	0.00071	0.00288	CcSEcCtD
Nitric Oxide—Nervous system disorder—Vincristine—kidney cancer	0.000703	0.00286	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Vincristine—kidney cancer	0.000702	0.00285	CcSEcCtD
Nitric Oxide—Dizziness—Vinblastine—kidney cancer	0.000674	0.00274	CcSEcCtD
Nitric Oxide—Dizziness—Everolimus—kidney cancer	0.000671	0.00273	CcSEcCtD
Nitric Oxide—Hypotension—Vincristine—kidney cancer	0.00067	0.00272	CcSEcCtD
Nitric Oxide—Bradycardia—Capecitabine—kidney cancer	0.00067	0.00272	CcSEcCtD
Nitric Oxide—Nervous system disorder—Gemcitabine—kidney cancer	0.000667	0.00271	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000666	0.00271	CcSEcCtD
Nitric Oxide—Haemoglobin—Capecitabine—kidney cancer	0.000661	0.00269	CcSEcCtD
Nitric Oxide—Haemorrhage—Capecitabine—kidney cancer	0.000658	0.00267	CcSEcCtD
Nitric Oxide—Dizziness—Erlotinib—kidney cancer	0.000648	0.00263	CcSEcCtD
Nitric Oxide—Headache—Vinblastine—kidney cancer	0.000638	0.00259	CcSEcCtD
Nitric Oxide—Headache—Everolimus—kidney cancer	0.000636	0.00258	CcSEcCtD
Nitric Oxide—Hypotension—Gemcitabine—kidney cancer	0.000636	0.00258	CcSEcCtD
Nitric Oxide—Headache—Erlotinib—kidney cancer	0.000614	0.00249	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000613	0.00249	CcSEcCtD
Nitric Oxide—Cardiac disorder—Capecitabine—kidney cancer	0.000611	0.00248	CcSEcCtD
Nitric Oxide—Dyspnoea—Gemcitabine—kidney cancer	0.000606	0.00246	CcSEcCtD
Nitric Oxide—Convulsion—Paclitaxel—kidney cancer	0.000605	0.00246	CcSEcCtD
Nitric Oxide—Angiopathy—Capecitabine—kidney cancer	0.000597	0.00243	CcSEcCtD
Nitric Oxide—Chest pain—Paclitaxel—kidney cancer	0.000594	0.00241	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Capecitabine—kidney cancer	0.000593	0.00241	CcSEcCtD
Nitric Oxide—Dizziness—Sorafenib—kidney cancer	0.000583	0.00237	CcSEcCtD
Nitric Oxide—Dizziness—Sunitinib—kidney cancer	0.000561	0.00228	CcSEcCtD
Nitric Oxide—Shock—Paclitaxel—kidney cancer	0.00056	0.00228	CcSEcCtD
Nitric Oxide—Nervous system disorder—Paclitaxel—kidney cancer	0.000559	0.00227	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000558	0.00227	CcSEcCtD
Nitric Oxide—Headache—Sorafenib—kidney cancer	0.000552	0.00224	CcSEcCtD
Nitric Oxide—Hypotension—Paclitaxel—kidney cancer	0.000532	0.00216	CcSEcCtD
Nitric Oxide—Headache—Sunitinib—kidney cancer	0.000531	0.00216	CcSEcCtD
Nitric Oxide—Dyspnoea—Paclitaxel—kidney cancer	0.000508	0.00206	CcSEcCtD
Nitric Oxide—Chest pain—Capecitabine—kidney cancer	0.000488	0.00198	CcSEcCtD
Nitric Oxide—Dizziness—Vincristine—kidney cancer	0.000474	0.00193	CcSEcCtD
Nitric Oxide—Shock—Capecitabine—kidney cancer	0.00046	0.00187	CcSEcCtD
Nitric Oxide—Nervous system disorder—Capecitabine—kidney cancer	0.000458	0.00186	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Capecitabine—kidney cancer	0.000458	0.00186	CcSEcCtD
Nitric Oxide—Headache—Vincristine—kidney cancer	0.000449	0.00183	CcSEcCtD
Nitric Oxide—Hypotension—Capecitabine—kidney cancer	0.000437	0.00178	CcSEcCtD
Nitric Oxide—Bradycardia—Doxorubicin—kidney cancer	0.000432	0.00175	CcSEcCtD
Nitric Oxide—Haemoglobin—Doxorubicin—kidney cancer	0.000426	0.00173	CcSEcCtD
Nitric Oxide—Headache—Gemcitabine—kidney cancer	0.000426	0.00173	CcSEcCtD
Nitric Oxide—Haemorrhage—Doxorubicin—kidney cancer	0.000424	0.00172	CcSEcCtD
Nitric Oxide—Dyspnoea—Capecitabine—kidney cancer	0.000417	0.00169	CcSEcCtD
Nitric Oxide—Cardiac disorder—Doxorubicin—kidney cancer	0.000394	0.0016	CcSEcCtD
Nitric Oxide—Angiopathy—Doxorubicin—kidney cancer	0.000385	0.00156	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Doxorubicin—kidney cancer	0.000382	0.00155	CcSEcCtD
Nitric Oxide—Dizziness—Paclitaxel—kidney cancer	0.000377	0.00153	CcSEcCtD
Nitric Oxide—Headache—Paclitaxel—kidney cancer	0.000357	0.00145	CcSEcCtD
Nitric Oxide—Convulsion—Doxorubicin—kidney cancer	0.00032	0.0013	CcSEcCtD
Nitric Oxide—Chest pain—Doxorubicin—kidney cancer	0.000314	0.00128	CcSEcCtD
Nitric Oxide—Dizziness—Capecitabine—kidney cancer	0.000309	0.00126	CcSEcCtD
Nitric Oxide—Shock—Doxorubicin—kidney cancer	0.000296	0.0012	CcSEcCtD
Nitric Oxide—Nervous system disorder—Doxorubicin—kidney cancer	0.000295	0.0012	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000295	0.0012	CcSEcCtD
Nitric Oxide—Headache—Capecitabine—kidney cancer	0.000293	0.00119	CcSEcCtD
Nitric Oxide—Hypotension—Doxorubicin—kidney cancer	0.000282	0.00114	CcSEcCtD
Nitric Oxide—Dyspnoea—Doxorubicin—kidney cancer	0.000269	0.00109	CcSEcCtD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—JUN—kidney cancer	0.000258	0.00167	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000255	0.00165	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000254	0.00164	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000254	0.00164	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000253	0.00164	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00025	0.00161	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000243	0.00157	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000242	0.00157	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000241	0.00156	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.000239	0.00155	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GLIPR1—kidney cancer	0.000238	0.00154	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PPAT—kidney cancer	0.000238	0.00154	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000238	0.00154	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—APRT—kidney cancer	0.000221	0.00143	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—FH—kidney cancer	0.000221	0.00143	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000213	0.00137	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GPC3—kidney cancer	0.000208	0.00134	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CA2—kidney cancer	0.000202	0.00131	CbGpPWpGaD
Nitric Oxide—Dizziness—Doxorubicin—kidney cancer	0.000199	0.00081	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—ALAD—kidney cancer	0.000197	0.00127	CbGpPWpGaD
Nitric Oxide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000196	0.00127	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—BRAF—kidney cancer	0.000195	0.00126	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000195	0.00126	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ST3GAL2—kidney cancer	0.000192	0.00124	CbGpPWpGaD
Nitric Oxide—Headache—Doxorubicin—kidney cancer	0.000189	0.000767	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—ALDH1A1—kidney cancer	0.000188	0.00122	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000187	0.00121	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PGK1—kidney cancer	0.00018	0.00117	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SLC5A3—kidney cancer	0.00018	0.00117	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000179	0.00116	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000178	0.00115	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—LDHB—kidney cancer	0.000177	0.00114	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—RAF1—kidney cancer	0.000176	0.00114	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—RAF1—kidney cancer	0.000176	0.00114	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	0.000175	0.00113	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.000175	0.00113	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—CYP1A1—kidney cancer	0.000175	0.00113	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	0.000173	0.00112	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	0.000172	0.00111	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTT1—kidney cancer	0.000172	0.00111	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000164	0.00106	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—RAF1—kidney cancer	0.000163	0.00105	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—PTGS1—kidney cancer	0.000161	0.00104	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IL2—kidney cancer	0.000158	0.00102	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IL2—kidney cancer	0.000158	0.00102	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—RAF1—kidney cancer	0.000157	0.00102	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CA9—kidney cancer	0.000153	0.000991	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000146	0.000943	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000145	0.00094	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000142	0.000916	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IL2—kidney cancer	0.000141	0.00091	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.00014	0.000904	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000138	0.000889	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000135	0.000874	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—VEGFA—kidney cancer	0.000134	0.000868	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—VEGFA—kidney cancer	0.000134	0.000868	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000133	0.000858	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CRABP1—kidney cancer	0.00013	0.000843	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—MAPK3—kidney cancer	0.000127	0.000821	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—MAPK3—kidney cancer	0.000127	0.000821	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ITPR2—kidney cancer	0.000121	0.000784	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—MAPK1—kidney cancer	0.000121	0.000781	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—MAPK1—kidney cancer	0.000121	0.000781	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	0.00012	0.000774	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—VEGFA—kidney cancer	0.00012	0.000774	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTP1—kidney cancer	0.000119	0.000769	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTP1—kidney cancer	0.000117	0.000758	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000115	0.000743	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—KRAS—kidney cancer	0.000114	0.000738	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—KRAS—kidney cancer	0.000114	0.000738	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—MAPK3—kidney cancer	0.000113	0.000732	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—MAPK1—kidney cancer	0.000112	0.000722	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTT1—kidney cancer	0.000111	0.000715	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ACHE—kidney cancer	0.000111	0.000715	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	0.00011	0.000711	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000109	0.000707	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTM1—kidney cancer	0.000109	0.000707	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000108	0.000698	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTM1—kidney cancer	0.000108	0.000697	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000108	0.000696	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—MAPK1—kidney cancer	0.000108	0.000696	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000107	0.000693	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000106	0.000683	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CA—kidney cancer	0.000105	0.000678	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CA—kidney cancer	0.000105	0.000678	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SCARB1—kidney cancer	0.000105	0.000676	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	0.000104	0.000674	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP1A1—kidney cancer	0.000104	0.00067	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTGS1—kidney cancer	0.000104	0.00067	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP1A1—kidney cancer	0.000102	0.000661	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—KRAS—kidney cancer	0.000102	0.000658	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PSMD7—kidney cancer	0.000102	0.000657	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TP53—kidney cancer	0.000101	0.000656	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TP53—kidney cancer	0.000101	0.000656	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTT1—kidney cancer	0.000101	0.000653	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	9.87e-05	0.000638	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	9.87e-05	0.000638	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	9.75e-05	0.00063	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	9.66e-05	0.000624	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—BCHE—kidney cancer	9.63e-05	0.000623	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SLC5A5—kidney cancer	9.51e-05	0.000615	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—PTGS1—kidney cancer	9.47e-05	0.000612	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	9.4e-05	0.000607	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CA—kidney cancer	9.35e-05	0.000604	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SLC2A1—kidney cancer	9.19e-05	0.000594	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ACY1—kidney cancer	9.12e-05	0.000589	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TP53—kidney cancer	9.04e-05	0.000585	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.87e-05	0.000573	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.57e-05	0.000554	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.35e-05	0.00054	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	8.21e-05	0.000531	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	8.15e-05	0.000527	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	7.8e-05	0.000504	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PDHB—kidney cancer	7.75e-05	0.000501	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—POMC—kidney cancer	7.73e-05	0.000499	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTP1—kidney cancer	7.66e-05	0.000495	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	7.55e-05	0.000488	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	7.39e-05	0.000478	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	7.31e-05	0.000472	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CCBL1—kidney cancer	7.29e-05	0.000471	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ABCB1—kidney cancer	7.25e-05	0.000469	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTM1—kidney cancer	7.04e-05	0.000455	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTP1—kidney cancer	7e-05	0.000453	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	6.98e-05	0.000451	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	6.91e-05	0.000447	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP1A1—kidney cancer	6.68e-05	0.000431	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.61e-05	0.000427	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTM1—kidney cancer	6.44e-05	0.000416	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	6.35e-05	0.00041	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GLIPR1—kidney cancer	6.32e-05	0.000408	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PPAT—kidney cancer	6.32e-05	0.000408	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	6.1e-05	0.000394	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	6.02e-05	0.000389	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—FH—kidney cancer	5.87e-05	0.00038	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—APRT—kidney cancer	5.87e-05	0.00038	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GPC3—kidney cancer	5.52e-05	0.000357	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5.41e-05	0.000349	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CA2—kidney cancer	5.37e-05	0.000347	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ACY1—kidney cancer	5.37e-05	0.000347	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	5.33e-05	0.000345	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ALAD—kidney cancer	5.24e-05	0.000338	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ST3GAL2—kidney cancer	5.11e-05	0.00033	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ALDH1A1—kidney cancer	4.99e-05	0.000323	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—POMC—kidney cancer	4.98e-05	0.000322	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.97e-05	0.000321	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.9e-05	0.000317	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PGK1—kidney cancer	4.79e-05	0.00031	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC5A3—kidney cancer	4.79e-05	0.00031	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.71e-05	0.000304	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—LDHB—kidney cancer	4.7e-05	0.000304	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.64e-05	0.0003	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.58e-05	0.000296	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PDHB—kidney cancer	4.56e-05	0.000295	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—POMC—kidney cancer	4.55e-05	0.000294	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CCBL1—kidney cancer	4.29e-05	0.000277	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ACY1—kidney cancer	4.14e-05	0.000268	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CA9—kidney cancer	4.07e-05	0.000263	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTGS2—kidney cancer	3.97e-05	0.000257	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.88e-05	0.000251	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.72e-05	0.00024	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PPAT—kidney cancer	3.72e-05	0.00024	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.67e-05	0.000237	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.64e-05	0.000235	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PDHB—kidney cancer	3.52e-05	0.000228	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—POMC—kidney cancer	3.51e-05	0.000227	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CRABP1—kidney cancer	3.46e-05	0.000224	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTEN—kidney cancer	3.46e-05	0.000224	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—FH—kidney cancer	3.46e-05	0.000224	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—APRT—kidney cancer	3.46e-05	0.000224	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.38e-05	0.000219	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CCBL1—kidney cancer	3.31e-05	0.000214	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GPC3—kidney cancer	3.25e-05	0.00021	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ITPR2—kidney cancer	3.22e-05	0.000208	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CA2—kidney cancer	3.16e-05	0.000204	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ALAD—kidney cancer	3.08e-05	0.000199	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ST3GAL2—kidney cancer	3.01e-05	0.000194	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.94e-05	0.00019	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ACHE—kidney cancer	2.94e-05	0.00019	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTT1—kidney cancer	2.94e-05	0.00019	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.87e-05	0.000186	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PPAT—kidney cancer	2.87e-05	0.000186	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.82e-05	0.000182	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PGK1—kidney cancer	2.82e-05	0.000182	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SCARB1—kidney cancer	2.78e-05	0.00018	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—LDHB—kidney cancer	2.77e-05	0.000179	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTGS1—kidney cancer	2.75e-05	0.000178	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PSMD7—kidney cancer	2.7e-05	0.000174	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—APRT—kidney cancer	2.67e-05	0.000173	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—FH—kidney cancer	2.67e-05	0.000173	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—BCHE—kidney cancer	2.56e-05	0.000165	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC5A5—kidney cancer	2.53e-05	0.000163	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GPC3—kidney cancer	2.51e-05	0.000162	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CA—kidney cancer	2.44e-05	0.000158	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CA2—kidney cancer	2.44e-05	0.000158	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.44e-05	0.000158	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CA9—kidney cancer	2.4e-05	0.000155	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ALAD—kidney cancer	2.38e-05	0.000154	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.34e-05	0.000151	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.32e-05	0.00015	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.27e-05	0.000147	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.18e-05	0.000141	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PGK1—kidney cancer	2.18e-05	0.000141	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—LDHB—kidney cancer	2.13e-05	0.000138	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CRABP1—kidney cancer	2.04e-05	0.000132	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTP1—kidney cancer	2.03e-05	0.000131	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ABCB1—kidney cancer	1.93e-05	0.000124	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ITPR2—kidney cancer	1.9e-05	0.000122	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTM1—kidney cancer	1.87e-05	0.000121	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CA9—kidney cancer	1.85e-05	0.00012	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.77e-05	0.000115	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.75e-05	0.000113	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTT1—kidney cancer	1.73e-05	0.000112	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ACHE—kidney cancer	1.73e-05	0.000112	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SCARB1—kidney cancer	1.64e-05	0.000106	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTGS1—kidney cancer	1.62e-05	0.000105	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PSMD7—kidney cancer	1.59e-05	0.000103	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CRABP1—kidney cancer	1.57e-05	0.000102	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—BCHE—kidney cancer	1.51e-05	9.73e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.49e-05	9.61e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ITPR2—kidney cancer	1.46e-05	9.45e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.44e-05	9.28e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.39e-05	9.01e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTT1—kidney cancer	1.33e-05	8.62e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ACHE—kidney cancer	1.33e-05	8.62e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—POMC—kidney cancer	1.32e-05	8.54e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SCARB1—kidney cancer	1.26e-05	8.16e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTGS1—kidney cancer	1.25e-05	8.08e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PSMD7—kidney cancer	1.23e-05	7.92e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.22e-05	7.85e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTP1—kidney cancer	1.2e-05	7.74e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—BCHE—kidney cancer	1.16e-05	7.51e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.15e-05	7.42e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ABCB1—kidney cancer	1.13e-05	7.33e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.11e-05	7.16e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTM1—kidney cancer	1.1e-05	7.12e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTGS2—kidney cancer	1.05e-05	6.81e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.04e-05	6.75e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTP1—kidney cancer	9.25e-06	5.98e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTEN—kidney cancer	9.19e-06	5.94e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ABCB1—kidney cancer	8.75e-06	5.66e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.57e-06	5.54e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTM1—kidney cancer	8.5e-06	5.49e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP1A1—kidney cancer	8.05e-06	5.21e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—POMC—kidney cancer	7.78e-06	5.03e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CA—kidney cancer	6.48e-06	4.19e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTGS2—kidney cancer	6.21e-06	4.01e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—POMC—kidney cancer	6e-06	3.88e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTEN—kidney cancer	5.41e-06	3.5e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTGS2—kidney cancer	4.79e-06	3.1e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTEN—kidney cancer	4.18e-06	2.7e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.82e-06	2.47e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.95e-06	1.9e-05	CbGpPWpGaD
